BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17711420)

  • 21. Evidence for Widespread Class II Microcins in
    Cole TJ; Parker JK; Feller AL; Wilke CO; Davies BW
    Appl Environ Microbiol; 2022 Dec; 88(23):e0148622. PubMed ID: 36394322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colicin V38 and microcin C38 produced by Escherichia coli strain 38.
    Leavitt RW; Braithwaite C; Jensen MM
    Avian Dis; 1997; 41(3):568-77. PubMed ID: 9356701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Microcins: their nature and genetic determination].
    Kurepina NE; Khmel' IA
    Mol Gen Mikrobiol Virusol; 1986 Apr; (4):3-9. PubMed ID: 3540636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of antilisterial bacteriocins.
    Berjeaud JM; Cenatiempo Y
    Methods Mol Biol; 2004; 268():225-33. PubMed ID: 15156034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Much of the microcin J25 leader peptide is dispensable.
    Cheung WL; Pan SJ; Link AJ
    J Am Chem Soc; 2010 Mar; 132(8):2514-5. PubMed ID: 20143810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic peptides derived from the sequence of a lasso peptide microcin J25 show antibacterial activity.
    Soudy R; Wang L; Kaur K
    Bioorg Med Chem; 2012 Mar; 20(5):1794-800. PubMed ID: 22304849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the genetic basis of natural resistance to microcins.
    Telhig S; Pham NP; Ben Said L; Rebuffat S; Ouellette M; Zirah S; Fliss I
    Microb Genom; 2024 Feb; 10(2):. PubMed ID: 38407259
    [No Abstract]   [Full Text] [Related]  

  • 28. Two enzymes catalyze the maturation of a lasso peptide in Escherichia coli.
    Duquesne S; Destoumieux-Garzón D; Zirah S; Goulard C; Peduzzi J; Rebuffat S
    Chem Biol; 2007 Jul; 14(7):793-803. PubMed ID: 17656316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identification and expression of plasmid genes participating in the synthesis of microcin C51].
    Fomenko DE; Basiuk EI; Bezrukov VM; Volodin AA; Metlitskaia AZ; Khmel' IA
    Genetika; 1996 Oct; 32(10):1326-32. PubMed ID: 9091404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation, purification and partial amino acid sequence of a highly hydrophobic new microcin named microcin L produced by Escherichia coli.
    Gaillard-Gendron S; Vignon D; Cottenceau G; Graber M; Zorn N; van Dorsselaer A; Pons AM
    FEMS Microbiol Lett; 2000 Dec; 193(1):95-8. PubMed ID: 11094285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microcins in
    Baquero F; Lanza VF; Baquero MR; Del Campo R; Bravo-Vázquez DA
    Front Microbiol; 2019; 10():2261. PubMed ID: 31649628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents.
    Collin F; Maxwell A
    J Mol Biol; 2019 Aug; 431(18):3400-3426. PubMed ID: 31181289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tying the knot: making of lasso peptides.
    Bierbaum G; Jansen A
    Chem Biol; 2007 Jul; 14(7):734-5. PubMed ID: 17656308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a lassoed tail.
    Wilson KA; Kalkum M; Ottesen J; Yuzenkova J; Chait BT; Landick R; Muir T; Severinov K; Darst SA
    J Am Chem Soc; 2003 Oct; 125(41):12475-83. PubMed ID: 14531691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microcins and urovirulence in Escherichia coli.
    Azpiroz MF; Poey ME; Laviña M
    Microb Pathog; 2009 Nov; 47(5):274-80. PubMed ID: 19744552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic analysis and complete primary structure of microcin L.
    Pons AM; Delalande F; Duarte M; Benoit S; Lanneluc I; Sablé S; Van Dorsselaer A; Cottenceau G
    Antimicrob Agents Chemother; 2004 Feb; 48(2):505-13. PubMed ID: 14742202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigations of the MceIJ-catalyzed posttranslational modification of the microcin E492 C-terminus: linkage of ribosomal and nonribosomal peptides to form "trojan horse" antibiotics.
    Nolan EM; Walsh CT
    Biochemistry; 2008 Sep; 47(35):9289-99. PubMed ID: 18690711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dawning of a 'Golden era' in lantibiotic bioengineering.
    Field D; Hill C; Cotter PD; Ross RP
    Mol Microbiol; 2010 Dec; 78(5):1077-87. PubMed ID: 21091497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lantibiotics and microcins: polypeptides with unusual chemical diversity.
    Jack RW; Jung G
    Curr Opin Chem Biol; 2000 Jun; 4(3):310-7. PubMed ID: 10826980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid identification of Escherichia coli microcin J25 producing strains using polymerase chain reaction and colony blot hybridization.
    Duarte M; Cottenceau G; Portrait V; Pons AM
    Can J Microbiol; 2001 Sep; 47(9):877-82. PubMed ID: 11683470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.